Xhale, Inc. is a medical technology company developing and commercializing patient-centric monitoring solutions for the healthcare industry.
Xhale, Inc. is currently focused on developing two broad technology platforms.
Through its Xhale SMART, Inc. subsidiary, Xhale, Inc. is developing a medication adherence monitoring technology which focuses on monitoring patient adherence to medication regimens established in protocols for investigation drugs in clinical trials.
The system will enable real-time call-backs to the trial participants within a short time after they miss a dose. The anticipated benefits can directly impact the success of drug approval, and help to provide safer, more effective drug development. We intend to initially apply our SMART® technology in the clinical trial market.
Xhale, Inc. was incorporated in Florida in 2005 and reincorporated in Delaware in 2008.